Andersen and Dopharma join forces in Spain!

Andersen and Dopharma announce the signing of a Joint Venture agreement for the marketing of their veterinary pharmaceutical products in Spain through a new company named  Dopharma Iberia.

Andersen, a veterinary pharmaceutical company with 45 years of experience since the beginning of its operations in Spain and export markets, also has a strong focus on excellence and specialization in nutritional products.

Dopharma, a Dutch veterinary pharmaceutical company with a focus on livestock, has been active for 50 years in the market and is currently selling its products in more than 80 countries around the world with approximately 70 distribution partners.

The combination of both portfolio’s, skills and expertise is joined now in Dopharma Iberia and will enforce their presence in the Spanish market and abroad.

The portfolio of Dopharma Iberia will consist of products for livestock including poultry, bovine, equine and swine. It includes both oral and injectable formulations.

Dopharma Iberia will start with their commercial operations in September 2019.

For any questions about the above announcement or our products please contact us: [email protected]


Dopharma Italia is born

On July 1st 2019, in the beautiful scenery of Iseo Lake, Dopharma International had its kick off meeting of the Italian direct to market business. Dopharma operates now serving their customers directly from a logistic platform near Milan with a portfolio including the recently acquired products from BI such a Prazil and Cefovet.

The Italian organization is led by Claudio Guarini as Country Manager and started with 5 sales agents whom are covering the Northern part of Italy, the area with the highest concentration of food producing animals.

The organization will be further strengthened within this year with both people and products marketed directly!

For more information:


European Bovine Congress 2019

From September 11-13, 2019 the European Bovine Congress will take place in ‘s-Hertogenbosch, the Netherlands. The theme is ‘your veterinary toolbox 2025’. Through technical and strategical sessions, new developments in the dairy industry and the veterinarians work field will be discussed.

Dopharma will be present with a booth.

Read the European Bovine Congress 2019 newsletter here.

More information about the congress is available on the European Bovine Congress website. Here you can also find the preliminary program.



Wijnand de Bruijn reappointed for another term as president of AnimalhealthEurope

We are pleased to inform you that during the assocition’s Board meeting held in Brussels on 5 June, the membership unanimously re-elected Wijnand de Bruijn from Dopharma as President of AnimalhealthEurope for what is essentially a third term.


How animal health is the forgotten factor in producing affordable, safe food for Europe

Despite the rise of vegetarianism and veganism in Europe, animal-source foods currently remain our only option for meeting the nutrient demands of a growing global population.

Animal protein is particularly important in developing countries where undernutrition is high, but widespread access to affordable and safe meat, fish, milk and eggs in Europe has also contributed to our nutrition security – and our freedom to choose a diverse diet.

Key factors in the high food safety standards that we enjoy in Europe are rigorous health policies and a robust animal health sector that provides effective animal medicines, and a culture of constant innovation.
Yet the role of animal health in guaranteeing affordable, healthy food in Europe is often misunderstood and under-valued.


Read the full article, written by Wijnand  de Bruijn, Dopharma’s CEO Business and President of Animal Health Europe, on the website of



Boehringer Ingelheim and Dopharma complete the acquisition of Saint-Herblon production site and Coophavet brand

Lyon, March 29th, 2019 – Following a pre-signing agreement in October 2018, Boehringer Ingelheim and Dopharma are announcing today the effective acquisition of the Saint-Herblon (France, Loire-Atlantique) production site and the Coophavet brand, by Dopharma.

Read the official press release  here (pdf):

Dopharma introduces Y-D-Fix®

Dopharma introduces Y-D-Fix®: innovation in weaning management

In pig farming we see several very persistent problems that can influence the health and results of piglets. An often mentioned problem for which no suitable solution is found yet, is the occurrence of poor performance post-weaning. The irregular feed uptake after weaning causes a decrease in intestinal health and a reduction in growth rate.

Dopharma is always looking for innovative ideas to solve problems in livestock farming. For the development of Y-D-Fix® we started from the physiological situation in the intestine of the healthy animal and the factors that play a major role in a suckling piglet.

Of course the mother’s milk of the sow is a crucial factor. Our research has shown that the composition of today’s sow milk is significantly different compared to the situation in the 1980’s and 90’s. The most prominent differences are in quantity of cholesterol and fats in the milk, possibly as a result of the changing genetic profile and feed of the sows.

Y-D-Fix® is a complementary dry feeding stuff for use in the farrowing unit and in the weaning phase, based on all benefits of sow milk. It is the result of years of research to find this patented composition and formulation.

Y-D-Fix® increases the feed intake of piglets before weaning and the composition provides fatty acids that are naturally present in sow milk. This results in an improved growth rate and more uniform feed uptake and contributes to a normal intestinal health.

The use of Y-D-Fix® is a totally new view on weaning management and gives piglets a brilliant kick off as fattening pig!

For more information, please contact your veterinarian or local Dopharma office or distributor or visit the Y-D-Fix website (Dutch). The initial launch will be focused on the Netherlands and Belgium. During ESPHM (22-24 May 2019, Utrecht) Dopharma will present Y-D-Fix® to the international public.



AnimalhealthEurope annual report 2018

The AnimalhealthEurope 2018 annual report is now available online.
As in previous years the annual report is a digital report with links back to key highlights from the past year. It is also available to download as an interactive PDF file.

The report includes:

  • A message from AnimalhealthEurope Secretary General, Roxane Feller and President, Wijnand de Bruijn;
  • Key facts and figures on the animal health sector including the latest European sales data for 2018
  • New EU rules adopted: what’s in store for animal health in the future.

New EU legislation

Recently, the new European legislation relating to veterinary medicines and medicated feed has been published.

It concerns the following regulations:

  • Regulation (EU) 2019/4 of the European Parliament and of the Council of 11 December 2018 on the manufacture, placing on the market and use of medicated feed, amending Regulation (EC) No 183/2005 of the European Parliament and of the Council and repealing Council Directive 90/167/EEC.
  • Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use.
  • Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC.

The consequences for other EU legislation are summarized in the table below.

The legislation will enter into force in the EU on 28 January 2019. Subsequently, there will be a transitional period of 3 years, which means that this legislation will become applicable on 28 January 2022.

New legislation Subject Amending Repealing
Regulation (EU) 2019/4 Medicated feed Regulation (EC) No 183/2005 Directive 90/167/EEC
Regulation (EU) 2019/5 Authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency Regulation (EC) No 726/2004

Regulation (EC) No 1901/2006

Directive 2001/83/EC

Regulation (EU) 2019/6 Veterinary medicinal products N.A. Directive 2001/82/EC

The original texts in different languages can be found on EUR-Lex:


Dopharma to purchase Boehringer generics manufacturing site in France

Boehringer Ingelheim and Dopharma announce a pre-signing for the acquisition of BI’s production site in Saint-Herblon. The proposed sale of the Saint-Herblon (France, Loire-Atlantique) production site had been announced in October 2017 following the presentation of Boehringer Ingelheim Animal Health strategic orientations. Now, one year later, we can announce that Dopharma is to make a significant addition to its manufacturing capabilities by purchasing assets from Boehringer Ingelheim.

Read the full press release here.